Dudley Matthew Z, Schuh Holly B, Goryn Michelle, Shaw Jana, Salmon Daniel A
Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Vaccines (Basel). 2023 Nov 21;11(12):1735. doi: 10.3390/vaccines11121735.
Few analyses of COVID-19 vaccine attitudes also cover routine vaccines or focus on parents. In this cross-sectional study, we surveyed US adults in September 2022, immediately following the authorization of updated bivalent COVID-19 boosters for adults but before their authorization for children. The vaccine attitudes of parents were compared to other adults. Fewer parents were up-to-date on COVID-19 vaccines than other adults (54% vs. 67%), even after adjusting for age, education, and race/ethnicity (Adjusted Odds Ratio: 0.58; 95% Confidence Interval: 0.45-0.76). More parents had concerns about COVID-19 vaccines' safety in children (67% vs. 58%; aOR: 1.59; 95%CI: 1.23-2.06) and vaccine ingredients (52% vs. 45%; aOR: 1.41; 95%CI: 1.09-1.81), and more parents perceived COVID-19 in children to be no worse than a cold or the flu (51% vs. 38%; aOR: 1.56; 95%CI: 1.22-2.01). Fewer parents supported COVID-19 vaccine school requirements (52% vs. 57%; aOR: 0.75; 95%CI: 0.58-0.97) and perceived high vaccine coverage among their friends (51% vs. 61%; aOR: 0.60; 95%CI: 0.46-0.78). However, three-quarters of parents intended their child to receive all routinely recommended vaccines, whereas only half of adults intended to receive all routinely recommended vaccines themselves. To improve parental informed vaccine decision-making, public health must ensure pediatric providers have updated resources to support their discussions of vaccine risks and benefits with their patients' parents.
很少有对新冠疫苗态度的分析涵盖常规疫苗或聚焦于父母群体。在这项横断面研究中，我们于2022年9月对美国成年人进行了调查，就在二价新冠加强针获批用于成年人之后、获批用于儿童之前。将父母的疫苗态度与其他成年人进行了比较。即使在对年龄、教育程度和种族/族裔进行调整后，接种新冠疫苗最新剂次的父母也比其他成年人少（54%对67%）（调整后的优势比：0.58；95%置信区间：0.45 - 0.76）。更多父母担心新冠疫苗对儿童的安全性（67%对58%；调整后的优势比：1.59；95%置信区间：1.23 - 2.06）以及疫苗成分（52%对45%；调整后的优势比：1.41；95%置信区间：1.09 - 1.81），并且更多父母认为儿童感染新冠并不比感冒或流感更严重（51%对38%；调整后的优势比：1.56；95%置信区间：1.22 - 2.01）。支持学校对新冠疫苗要求的父母较少（52%对57%；调整后的优势比：0.75；95%置信区间：0.58 - 0.97），且认为其朋友中疫苗接种率高的父母较少（51%对61%；调整后的优势比：0.60；95%置信区间：0.46 - 0.78）。然而，四分之三的父母打算让他们的孩子接种所有常规推荐疫苗，而只有一半的成年人打算自己接种所有常规推荐疫苗。为改善父母在疫苗决策方面的知情程度，公共卫生部门必须确保儿科医疗服务提供者有最新的资源来支持他们与患者父母讨论疫苗的风险和益处。
